

Manifestations of salivary gland pathology in patients after radioiodine therapy for thyroid diseases
https://doi.org/10.33667/2078-5631-2025-1-22-29
Abstract
Radioiodine therapy is performed for highly differentiated papillary and follicular prostate cancer. The manifestation of the side effect of radioiodine therapy on the salivary glands leads to structural and functional changes in healthy organs.
Background. The presence of persistent symptoms and manifestations of sialoadenitis underscores the need to find preventive measures for radio-induced sialoadenitis. The combination of a history of thyroid cancer and concomitant complications of salivary gland diseases requires dynamic monitoring and determination of the quality of life of this group of patients after RT.
Material and methods. As a result of the examination of 70 patients at different times after radiation therapy, various combinations of damage to one or more salivary glands were identified and described in this article during clinical and X-ray examination. According to the sociological survey and laboratory diagnosis of thyroid hormones, the assessment of the quality of life of these patients was carried out. Statistical processing of the obtained results.
Results. It was revealed that the development of post-radiation sialoadenitis in the early and delayed periods after radioiodine therapy is characterized by a variety of clinical and structural manifestations. The presence of thyroid cancer and pronounced radio-induced manifestations from the salivary glands significantly affect the quality of life of patients.
Conclusions. The progression of salivary gland disease does not depend on the administered total therapeutic dose of sodium iodide, gender, age. The undesirable effects of radioiodine therapy on the salivary glands against the background of thyroid disease negatively affect the quality of life.
About the Authors
E. I. DubrovinaRussian Federation
Dubrovina Elena Igorevna, assistant of the Dept. of propaedeutics surgical dentistry
Moscow
I. V. Gaiduk
Russian Federation
Gaiduk Igor Viktorovich, Ph.D. Associate Professor of the Dept. propaedeutics of surgical dentistry
Moscow
A. M. Panin
Russian Federation
Panin Andrey Mikhailovich, DM Sci. Prof., Head of the Dept. propaedeutics of surgical dentistry
Moscow
A. M. Tsitsiashvili
Russian Federation
Tsitsiashvili Alexander Mikhailovich, DM, Sci. Prof of the Dept. propaedeutics of surgical dentistry
Moscow
References
1. Abrosimov A.Yu., Abdulkhabirova F.M., Nikankina L.V., Troshina E.A. Laboratory diagnostics of thyroid tumor diseases. Consilium Medicum. 2019;21(12):31–47. DOI: 10.26442/20751753.2019.12.190682.
2. Zolotukhin S.Y. The use of sialoendoscopy for the diagnosis and treatment of patients with radioiode-associated sialoadenitis. Xerostomia.Selected lectures. Under the general editorship of A.V. Shchipsky. [Afanasyev V.V., Sadovsky V.V., Shchipsky A.V. and others]. Moscow: Tver: OOO Publishing House Triada, 2024. 400s.
3. Kovalenko V.A., Kopchak A.V., Kovalenko A.E. Post-radiation sialozoadenitis in patients with papillary carcinomas of the thyroid gland. Bulletin of Surgery. Volume 174. – No. 1. – 2015. – pp. 75–77.
4. Malanchuk V.O., Kopchak A.V., Kovalenko V.A. Clinical manifestations of salivary gland dysfunction in patients treated with radioactive iodine for papillary thyroid carcinoma. Bulletin of Dentistry No. 1. – 2013 – pp. 61–65.
5. Reinberg M.V., Slashchuk K.Yu., Trukhin A.A., Avramova K.I., Sheremeta M.S. A modern view on the main aspects of preparing patients with differentiated thyroid cancer for radioiodine therapy: a scientific review // Digital Diagnostics. 2023. Vol. 4, No. 4. pp. 543–568. DAY: https://doi.org/10.17816/DD532728.
6. Rodichev A.A. The use of radioactive iodine in the treatment of differentiated thyroid cancer. Tironet, No. 4, 2003.
7. Rumyantsev P.O., Degtyarev M.V., Dzeitova D.S., Trukhin A.A., Slashchuk K.Yu., Sheremeta M.S., Sergenko S.S., Yasyuchenya V.S., Sirota Ya.I. Scintigraphy in the diagnosis of diffuse and nodular thyroid pathology. Clinical and experimental thyroidology. 2019;15(4):138–147.https://doi.org/10.14341/ket12240.
8. Skibitskaya M.V., Kuznetsov N.S. Modern aspects affecting the management of patients with papillary thyroid cancer. Surgery. The N.I. Pirogov. 2023;(12):89–94.
9. Sultimova T.B., Kozlova M.V., Gaponov A.M., Savlevich E.L., Kozlov I.G. Local cytokine status in patients with sialadenosis of the parotid salivary gland on the background of hypothyroidism. Immunology. 2021;43(4):356–363.
10. Sultimova T. B., Kozlova M. V., Mkrtumyan A.M. The influence of thyroid pathology on the development of sialadenosis // Kremlin medicine. Clinical Bulletin. 2019. Vol. 2. No. 4. pp. 47–51.
11. Chernikov R.A., Valdina E.A., Vorobyev S.L., Sleptsov I.V. Long-term results of surgical treatment for papillary thyroid cancer and a comparative assessment of treatment tactics. Clinical and experimental thyroidology. 2014;10(1):31–37. https://doi.org/10.14341/CET201410131-37.
12. Shurinov A.Y., Borodavina E.V., Krylov V.V., Sigov M.A., Rodichev A.A., Ivanov S.A., Kaprin A.D. Methodological recommendations for radiotherapy in patients with differentiated thyroid cancer and post-therapeutic control. Tumors of the head and neck. 2024;14(1):83–95. https://doi.org/10.17650/2222-1468-2024-14-1-83-95.
13. Yaremenko A.I., Kutukova S.I., Razumova A.Y., Baykalova P.M. Chronic sialadenitis as a complication of radiotherapy. Institute of Dentistry. – 2018 – 1- p. 14.
14. Yaremenko A.I., Razumova A.Ya., Petrov N.L., Kutukova S.I., Vase.L. Intra-ductal surgery of salivary glands of patients. Medical almanac. – 2023; № 2 (75). C. 89–93.
15. Alexander, C., Bader, J.B., Schaefer, A., Finke, C. and Kirsch, C.M. (1998) Intermediate and Long-Term Side Effects of High-Dose Radioiodine Therapy for Thyroid Carcinoma. Journal of Nuclear Medicine, 39, 1551–1554.
16. Almeida, J.P., Sanabria, Á.E., Lima, E.N.P., & Kowalski, L.P. (2010). Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head & Neck, 33(5), 686–690.
17. Arunrat A., Jaruwan S., Thunyarat A., Sirimon R.,Chutintorn S. Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials. Thyroid Endocrinology Vol. 13 – 2022. https://doi.org/10.3389/fendo.2022.960265.
18. Hyer S., Kong A., Pratt B., Harmer C. Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol) 2007. doi: 10.1016/j.clon.2006.11.005
19. Jeong S. Y., Kim H. W., Lee S. W. et al. Salivaryglandfunction 5 yearsafterradioactiveiodineablationinpatientswithdifferentiated thyroid cancer: direct comparison of pre- and postablationscintigraphies and their relation to xerostomia symptoms // Thyroid. 2013. Vol. 23, № 5. P. 609–616.
20. La Perle K.M., Kim D.C., Hall N.C., Bobbey A., Shen D.H., Nagy R.S., Wakely P.E. Jr, Lehman A., Jarjoura D., Jhiang S.M. Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid. 2013 Aug;23(8):1029-36. doi: 10.1089/thy.2012.0571.
21. Le Roux M.K., Graillon N., Guyot L. Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study. Head & Neck. 2020;42(11):3133–3140. doi: 10.1002/hed.26359.
22. Mandel S.J, Mandel L. Radioactive iodine and the salivary glands. Thyroid (2003) 13(3):265–71. doi: 10.1089/105072503321582060.
23. Rashka S., Liu Yu., Mirjalili V. Machine learning with PyTorch and Scikit-Learn (Machine Learning with Python and Scikit-Learn): 2024. – St. Petersburg: Foliant. – P. 688.
24. Van Nostrand D. Sialoadenitis secondary to 131I therapy for well-differentiated thyroid cancer. Oral Dis (2011) 17(2):154–61. doi: 10.1111/j.1601-0825.2010.01726.x.
25. Wasserman L. All of Statistics: A Concise Course in Statistical Inference (Springer Texts in Statistics). 2004. P. 458.
Review
For citations:
Dubrovina E.I., Gaiduk I.V., Panin A.M., Tsitsiashvili A.M. Manifestations of salivary gland pathology in patients after radioiodine therapy for thyroid diseases. Medical alphabet. 2025;(1):22-29. (In Russ.) https://doi.org/10.33667/2078-5631-2025-1-22-29